Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Childhood cancer survivorship: barriers and preferences.

Signorelli C, Wakefield C, McLoone JK, Fardell J, Jones JM, Turpin KH, Emery J, Michel G, Downie P, Skeen JE, Cohn R; ANZCHOG Survivorship Study Group; members of the ANZCHOG Survivorship Study Group.

BMJ Support Palliat Care. 2019 Nov 11. pii: bmjspcare-2019-002001. doi: 10.1136/bmjspcare-2019-002001. [Epub ahead of print]

PMID:
31712388
2.

Early Neurodevelopmental Exposure to Low Lead Levels Induces Fronto-executive Dysfunctions That Are Recovered by Taurine Co-treatment in the Rat Attention Set-Shift Test: Implications for Taurine as a Psychopharmacotherapy Against Neurotoxicants.

Neuwirth LS, Kim Y, Barrerra ED, Jo C, Chrisphonte JM, Hameed N, Rubi S, Dacius TF Jr, Skeen JC, Bonitto JR, Khairi E, Iqbal A, Ahmed I, Masood S, Tranquilee B, Thiruverkadu V.

Adv Exp Med Biol. 2019;1155:821-846. doi: 10.1007/978-981-13-8023-5_70.

PMID:
31468450
3.

Assessing the Anxiolytic Properties of Taurine-Derived Compounds in Rats Following Developmental Lead Exposure: A Neurodevelopmental and Behavioral Pharmacological Pilot Study.

Neuwirth LS, Emenike BU, Barrera ED, Hameed N, Rubi S, Dacius TF Jr, Skeen JC, Bonitto JR, Khairi E, Iqbal A, Ahmed I, Jose TJ, Lynch K, Khan M, Alvira AL, Mathew N, Kaur S, Masood S, Tranquilee B, Thiruverkadu V.

Adv Exp Med Biol. 2019;1155:801-819. doi: 10.1007/978-981-13-8023-5_69.

PMID:
31468449
4.

Cancer control in the Pacific: big challenges facing small island states.

Sarfati D, Dyer R, Sam FA, Barton M, Bray F, Buadromo E, Ekeroma A, Foliaki S, Fong J, Herman J, Huggins L, Maoate K, Meredith I, Mola G, Palafox N, Puloka V, Shin HR, Skeen J, Snowdon W, Tafuna'i M, Teng A, Watters D, Vivili P.

Lancet Oncol. 2019 Sep;20(9):e475-e492. doi: 10.1016/S1470-2045(19)30400-0. Epub 2019 Aug 5. Review.

PMID:
31395476
5.

Cancer management in the Pacific region: a report on innovation and good practice.

Ekeroma A, Dyer R, Palafox N, Maoate K, Skeen J, Foliaki S, Vallely AJ, Fong J, Hibma M, Mola G, Reichhardt M, Taulung L, Aho G, Fakakovikaetau T, Watters D, Toliman PJ, Buenconsejo-Lum L, Sarfati D.

Lancet Oncol. 2019 Sep;20(9):e493-e502. doi: 10.1016/S1470-2045(19)30414-0. Epub 2019 Aug 5. Review.

PMID:
31395474
6.

Identification of new Wilms tumour predisposition genes: an exome sequencing study.

Mahamdallie S, Yost S, Poyastro-Pearson E, Holt E, Zachariou A, Seal S, Elliott A, Clarke M, Warren-Perry M, Hanks S, Anderson J, Bomken S, Cole T, Farah R, Furtwaengler R, Glaser A, Grundy R, Hayden J, Lowis S, Millot F, Nicholson J, Ronghe M, Skeen J, Williams D, Yeomanson D, Ruark E, Rahman N.

Lancet Child Adolesc Health. 2019 May;3(5):322-331. doi: 10.1016/S2352-4642(19)30018-5. Epub 2019 Mar 16.

7.

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.

Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B, Skeen J, Mateos ME, Capra M, Rangaswami AA, Ansari M, Rechnitzer C, Veal GJ, Covezzoli A, Brugières L, Perilongo G, Czauderna P, Morland B, Neuwelt EA.

N Engl J Med. 2018 Jun 21;378(25):2376-2385. doi: 10.1056/NEJMoa1801109.

8.

Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.

Halliday BJ, Fukuzawa R, Markie DM, Grundy RG, Ludgate JL, Black MA, Skeen JE, Weeks RJ, Catchpoole DR, Roberts AGK, Reeve AE, Morison IM.

PLoS Genet. 2018 Jun 18;14(6):e1007399. doi: 10.1371/journal.pgen.1007399. eCollection 2018 Jun.

9.

Childhood cancer registration in New Zealand: A registry collaboration to assess and improve data quality.

Ballantine KR, Hanna S, Macfarlane S, Bradbeer P, Teague L, Hunter S, Cross S, Skeen J.

Cancer Epidemiol. 2018 Aug;55:104-109. doi: 10.1016/j.canep.2018.06.001. Epub 2018 Jun 11.

PMID:
29902672
10.

Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade.

Tonorezos ES, Barnea D, Cohn RJ, Cypriano MS, Fresneau BC, Haupt R, Hjorth L, Ishida Y, Kruseova J, Kuehni CE, Kurkure PA, Langer T, Nathan PC, Skeen JE, Skinner R, Tacyildiz N, van den Heuvel-Eibrink MM, Winther JF, Hudson MM, Oeffinger KC.

J Clin Oncol. 2018 Jul 20;36(21):2223-2230. doi: 10.1200/JCO.2017.76.5180. Epub 2018 Jun 6. Review.

11.

Attitudes and experiences of childhood cancer survivors transitioning from pediatric care to adult care.

Nandakumar BS, Fardell JE, Wakefield CE, Signorelli C, McLoone JK, Skeen J, Maguire AM, Cohn RJ; ANZCHOG Survivorship Study Group.

Support Care Cancer. 2018 Aug;26(8):2743-2750. doi: 10.1007/s00520-018-4077-5. Epub 2018 Mar 2.

PMID:
29500581
12.

Transition of childhood cancer survivors to adult care: The survivor perspective.

Fardell JE, Wakefield CE, Signorelli C, Hill R, Skeen J, Maguire AM, McLoone JK, Cohn RJ; ANZCHOG survivorship study group.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26354. Epub 2016 Nov 5. No abstract available.

PMID:
28436208
13.

Sensitivity of a real-time PCR method for the detection of transgenes in a mixture of transgenic and non-transgenic seeds of papaya (Carica papaya L.).

Nageswara-Rao M, Kwit C, Agarwal S, Patton MT, Skeen JA, Yuan JS, Manshardt RM, Stewart CN Jr.

BMC Biotechnol. 2013 Sep 1;13:69. doi: 10.1186/1472-6750-13-69.

14.

Concussions in soccer: a current understanding.

Levy ML, Kasasbeh AS, Baird LC, Amene C, Skeen J, Marshall L.

World Neurosurg. 2012 Nov;78(5):535-44. doi: 10.1016/j.wneu.2011.10.032. Epub 2011 Nov 1.

PMID:
22120567
15.

Outsourcing to win.

Fink P, Skeen J.

Med Device Technol. 2007 Nov-Dec;18(7):23-4. Review.

PMID:
18075130
16.

Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner.

Skeen JE, Bhaskar PT, Chen CC, Chen WS, Peng XD, Nogueira V, Hahn-Windgassen A, Kiyokawa H, Hay N.

Cancer Cell. 2006 Oct;10(4):269-80.

17.

Caregivers in death, dying, and bereavement situations.

International Work Group on Death, Dying, and Breavement, Corr CA, Corr DM, Goldman C, Jupp P, Lattanzi-Licht M, Papadatou D, Rybarik MF, Skeen J, Smeding R, Sourkes B, Thompson N.

Death Stud. 2006 Sep;30(7):649-63.

PMID:
16865827
18.

Prospective audit of treatment of paediatric febrile neutropenia in Australasia.

Chamberlain JD, Smibert E, Skeen J, Alvaro F.

J Paediatr Child Health. 2005 Nov;41(11):598-603.

PMID:
16398846
19.

Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.

Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N.

J Biol Chem. 2005 Sep 16;280(37):32081-9. Epub 2005 Jul 15.

20.

A gene expression signature for relapse of primary wilms tumors.

Li W, Kessler P, Yeger H, Alami J, Reeve AE, Heathcott R, Skeen J, Williams BR.

Cancer Res. 2005 Apr 1;65(7):2592-601.

21.

Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.

Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Chandel NS, Thompson CB, Robey RB, Hay N.

Mol Cell. 2004 Dec 3;16(5):819-30.

22.

Inhibition of Chk1 by activated PKB/Akt.

King FW, Skeen J, Hay N, Shtivelman E.

Cell Cycle. 2004 May;3(5):634-7. Epub 2004 May 31.

PMID:
15107605
23.

Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N.

Genes Dev. 2003 Jun 1;17(11):1352-65.

24.

Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.

Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N.

Mol Cell Biol. 2002 Nov;22(22):7831-41.

25.

Decomposition chemistry of human remains: a new methodology for determining the postmortem interval.

Vass AA, Barshick SA, Sega G, Caton J, Skeen JT, Love JC, Synstelien JA.

J Forensic Sci. 2002 May;47(3):542-53.

PMID:
12051334
26.

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.

Rapley EA, Barfoot R, Bonaïti-Pellié C, Chompret A, Foulkes W, Perusinghe N, Reeve A, Royer-Pokora B, Schumacher V, Shelling A, Skeen J, de Tourreil S, Weirich A, Pritchard-Jones K, Stratton MR, Rahman N.

Br J Cancer. 2000 Jul;83(2):177-83.

27.

Childhood cancer in New Zealand 1990 to 1993.

Becroft DM, Dockerty JD, Berkeley BB, Chan YF, Lewis ME, Skeen JE, Synek BJ, Teague LR.

Pathology. 1999 May;31(2):83-9.

PMID:
10399160
28.
29.

Good prognosis of cellular mesoblastic nephroma with hyperdiploidy and relaxation of imprinting of the maternal IGF2 gene.

Becroft DM, Mauger DC, Skeen JE, Ogawa O, Reeve AE.

Pediatr Pathol Lab Med. 1995 Sep-Oct;15(5):679-88.

PMID:
8597855
30.

Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism.

Ogawa O, Becroft DM, Morison IM, Eccles MR, Skeen JE, Mauger DC, Reeve AE.

Nat Genet. 1993 Dec;5(4):408-12.

PMID:
8298652
31.

Childhood cancer among the Polynesian population.

Ridgway D, Skeen JE, Mauger DC, Becroft DM.

Cancer. 1991 Jul 15;68(2):451-4.

PMID:
2070341
32.

Intraoperative pulse oximetry in peripheral revascularization in an infant.

Skeen JT, Backus WW, Hovagim AR, Poppers PJ.

J Clin Monit. 1988 Oct;4(4):272-3.

PMID:
3193151
33.

Ultrastructural heterogeneity in cerebral amyloid of Alzheimer's disease.

Powers JM, Skeen JT.

Acta Neuropathol. 1988;76(6):613-23.

PMID:
3201924
34.

Varied uses of a thiopental infusion.

Katz RI, Skeen JT, Quartararo C, Poppers PJ.

Anesth Analg. 1987 Dec;66(12):1328-30. No abstract available.

PMID:
3688508
35.

Comparison of learning disabled children's performance on Bender Visual-Motor Gestalt Test and Beery's Developmental Test of Visual Motor Integration.

Skeen JA, Strong VN, Book RM.

Percept Mot Skills. 1982 Dec;55(3 Pt 2):1257-8. No abstract available.

PMID:
7167322
36.

Scent of gerbil cuisine.

Skeen JT, Thiessen DD.

Physiol Behav. 1977 Jul;19(1):11-4.

PMID:
11803671
37.

Retention of learned temperature changes during problem solving.

Willerman L, Skeen JT, Simpson JS.

Percept Mot Skills. 1976 Dec;43(3 pt. 1):995-1002.

PMID:
1012880
38.

THE MEASUREMENT OF STIMULUS COMPLEXITY IN HIGH-RESOLUTION SENSOR IMAGERY. TECHN DOCUM REP NO. AMRL-TDR-64-29.

NYGAARD JE, SLOCUM GK, THOMAS JO, SKEEN JR, WOODHULL JG.

AMRL TR. 1964 May:1-276. No abstract available.

PMID:
14292658
39.

EXPERIMENTS WITH TRIANEA ON ANTAGONISM AND ABSORPTION.

Skeen JR.

Plant Physiol. 1930 Jan;5(1):105-18. No abstract available.

40.

SPONTANEOUS RUPTURE OF THE HEART.

Skeen JH, Dow DR.

Br Med J. 1925 Feb 7;1(3345):262-3. No abstract available.

Supplemental Content

Support Center